![Mohammad Masjedizadeh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mohammad Masjedizadeh
Direttore Tecnico/Scientifico/R&S presso PROTAGONIST THERAPEUTICS, INC.
Provenienza dei contatti di primo grado di Mohammad Masjedizadeh
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 31 | |
Roche Pharmaceuticals, Inc.
![]() Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ.
30
| Subsidiary | Miscellaneous Commercial Services | 30 |
Roche Palo Alto LLC
![]() Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA.
15
| Subsidiary | Pharmaceuticals: Major | 15 |
Subsidiary | Pharmaceuticals: Major | 9 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Mohammad Masjedizadeh tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ALZA CORPORATION | Pharmaceuticals: Major | Chairman Sales & Marketing Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Private Equity Investor | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal President Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
PHARMACYCLICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
F. Hoffmann-La Roche Ltd.
![]() F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member President Human Resources Officer | |
XOMA CORPORATION | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
INTERMUNE INC | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
PricewaterhouseCoopers LLP
![]() PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Protagonist Pty Ltd.
![]() Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Yale University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Stanford University | College/University | Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
New Leaf Venture Partners LLC
![]() New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Sofinnova Investments, Inc.
![]() Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree Corporate Officer/Principal | |
SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
Janssen Pharmaceuticals, Inc.
![]() Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
PDL BIOPHARMA, INC. | Biotechnology | Director/Board Member Chairman Comptroller/Controller/Auditor | |
Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Roche Bioscience
![]() Roche Bioscience Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Bioscience is a company that discovers and develops prescription drugs. The company is based in Palo Alto, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer President Corporate Officer/Principal | |
Samsara Biocapital LLC
![]() Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
University of Illinois At Urbana–Champaign | College/University | Undergraduate Degree Graduate Degree | |
The University of Chicago | College/University | Graduate Degree Undergraduate Degree | |
CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Rutgers State University of New Jersey | College/University | Doctorate Degree Doctorate Degree | |
BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Chairman Chief Operating Officer | |
MiroBio Ltd.
![]() MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chief Tech/Sci/R&D Officer Chairman | |
DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
RAIN ONCOLOGY INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
CAREDX, INC | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
DOT Therapeutics-2, Inc.
![]() DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Founder Director/Board Member | |
ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Founder Director of Finance/CFO | |
DuPont Pharmaceuticals Co.
![]() DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
SPYRE THERAPEUTICS, INC. | Biotechnology | Chairman Chief Executive Officer |
Statistiche
Distribuzione geografica
Stati Uniti | 45 |
Svizzera | 2 |
Australia | 2 |
Giappone | 2 |
Finlandia | 2 |
Settori
Health Technology | 35 |
Consumer Services | 11 |
Finance | 4 |
Commercial Services | 3 |
Posizioni
Director/Board Member | 313 |
Corporate Officer/Principal | 220 |
Chief Tech/Sci/R&D Officer | 99 |
Independent Dir/Board Member | 85 |
Undergraduate Degree | 64 |
Contatti più connessi
Insiders | |
---|---|
Robert Stein | 34 |
Jim Woody | 31 |
David Kabakoff | 30 |
Samuel Saks | 28 |
William Burns | 27 |
Harold Selick | 24 |
Robert Booth | 23 |
Lewis Williams | 23 |
Herbert Conrad | 21 |
Joseph McCracken | 20 |
William Waddill | 19 |
Sarah Noonberg | 17 |
Alan Henry Raffensperger | 17 |
Armen Shanafelt | 17 |
Michael Dybbs | 17 |
- Borsa valori
- Insiders
- Mohammad Masjedizadeh
- Connessioni Società